ALNYLAM PHARMACEUTICALS INC. Common Stock cmn shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of ALNYLAM PHARMACEUTICALS INC. Common Stock cmn shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in ALNYLAM PHARMACEUTICALS INC. Common Stock cmn
Tip: Access up to 7 years of quarterly data
All positions including ALNYLAM PHARMACEUTICALS INC. Common Stock cmn held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in ALNYLAM PHARMACEUTICALS INC. Common Stock cmn by Jpmorgan Chase & Co
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $3.8M | 20k | 191.41 |
2023-06-30 | $1.4M | 7.5k | 189.94 |
2023-03-31 | $1.5M | 7.5k | 200.27 |
2022-06-30 | $12M | 84k | 145.85 |
2022-03-31 | $12M | 71k | 163.30 |
2021-12-31 | $33M | 193k | 169.58 |
2020-12-31 | $1.3M | 10k | 130.00 |
2019-06-30 | $15M | 215k | 71.08 |
2018-09-30 | $2.6M | 30k | 87.53 |
2018-06-30 | $2.7M | 27k | 98.48 |
2018-03-31 | $3.2M | 27k | 119.11 |
Top funds holding ALNYLAM PHARMACEUTICALS INC. Common Stock cmn
View all funds holding ALNYLAM PHARMACEUTICALS INC. Common Stock cmn